First published: Tue Jun 13 2023(Updated: )
The Alaris Infusion Central software, versions 1.1 to 1.3.2, may contain a recoverable password after the installation. No patient health data is stored in the database, although some site installations may choose to store personal data.
Credit: cybersecurity@bd.com
Affected Software | Affected Version | How to fix |
---|---|---|
Bd Alaris Infusion Central | >=1.1<=1.3.2 |
Sign up to SecAlerts for real-time vulnerability data matched to your software, aggregated from hundreds of sources.
CVE-2022-47376 is a vulnerability in the Alaris Infusion Central software versions 1.1 to 1.3.2 that may contain a recoverable password after installation.
The severity of CVE-2022-47376 is high, with a CVSS score of 7.3.
The Alaris Infusion Central software versions 1.1 to 1.3.2 are affected by CVE-2022-47376.
No, no patient health data is stored in the database.
Some site installations may choose to store personal data.
To fix CVE-2022-47376, update the Alaris Infusion Central software to a version higher than 1.3.2.
You can find more information about CVE-2022-47376 at the following link: https://www.bd.com/en-us/about-bd/cybersecurity/bulletin/alaris-infusion-central-recoverable-password-vulnerability
CWE-522 is a weakness in the Alaris Infusion Central software that allows a recoverable password after installation.
CWE-257 is a weakness in the Alaris Infusion Central software that allows environmental variables to be overwritten or modified.